MichaelRivnerMD

Neurology • Macon, GA

Neuromuscular Medicine, Neurophysiology, Pain Medicine

Charbonnier Professor of Neurology Georgia Health Sciences University

Join to view full profile

Dr. Rivner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rivner's full profile

Already have an account?

Office
3351 Northside Dr
Macon, GA 31210
Phone+1 478-201-6629

Fax+1 706-721-8701

Education & Training

Medical College of GeorgiaFellowship, Pain Medicine, 1982 - 1983
Medical College of GeorgiaResidency, Neurology, 1978 - 1982
Emory University School of MedicineClass of 1978

Certifications & Licensure

GA State Medical License 1979 - 2025
SC State Medical License 1980 - 2025
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Gilenya in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
Completed
Phase 2
Clinical Trial of Ezogabine (Retigabine) in ALS Subjects Start of enrollment: 2015 Jun 01
Completed
Phase 2
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS Start of enrollment: 2020 May 28
Recruiting
Phase 2, Phase 3

Publications & Presentations

PubMed

Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-b...
Vera Bril, Tomasz Berkowicz, Andrzej Szczudlik, Michael W Nicolle, Josef Bednarik
Muscle & Nerve. 2025-01-01
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial.
Steven Perrin, Shafeeq Ladha, Nicholas Maragakis, Michael H Rivner, Jonathan Katz
Plos Medicine. 2024-10-01
1 citations
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investiga...
Luis Querol, Jérôme De Sèze, Tina Dysgaard, Todd Levine, T Hemanth Rao
Journal of Neurology, Neurosurgery, and Psychiatry. 2024-08-16

Journal Articles

Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis
Brian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology

Press Mentions

'This Is Horrible': Future of Central and South Georgia's Only Clinic for ALS Patients UncertainOctober 26th, 2022
Augusta Clinic, MCG Student Focus on Patient, Family in Treatment of ALSMay 21st, 2021
1st Patient Enrolled in Phase 2a Trial Testing AT-1501 in ALSNovember 4th, 2020
Join now to see all